Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nagambie Resources Ltd V.NAG


Primary Symbol: NGMBF

Nagambie Resources Limited is an Australia-based natural resources exploration company. The principal activities of the Company include exploration for, and development of, gold, associated minerals including antimony, and construction materials in Australia, and the investigation and development of waste handling assets. The Company is focused on targeting epitherm alantimony-gold mineralized systems across 3,200 square kilometers of tenements in the Waranga Domain of the Melbourne Structural Zone, in Victoria, Australia. The Company's flagship project is the Antimony-Gold Project, which sits in proximity to the gold-antimony mines at Fosterville (Agnico Eagle) and Costerfield (Mandalay Resources). The Antimony-Gold Project is located at the 100% owned Nagambie Mine. Its Whroo Goldfields project is located approximately 130 kilometers (km) north of Melbourne. It also holds interest in Whroo Project, PASS Project, and Sand Project.


OTCPK:NGMBF - Post by User

Bullboard Posts
Comment by 13thon Feb 13, 2008 12:00am
192 Views
Post# 14363875

RE: load up for the next P&D

RE: load up for the next P&DPhotobucket"""-----INNEXUS BIOTECHNOLOGY INC ( IXS.V )-----"""size=4>color=RED> MAJOR NEWS----InNexus says study shows DXL625 kills tumour cellssize=4> INNEXUS BIOTECHNOLOGY ( TRADING JUST AT 0.35 CENTS ) ANNOUNCES PRELIMINARY RESULTS OF ANIMAL STUDY COMPARING CANCER KILLING ACTIVITY OF ITS DXL625 (CD20) TREATMENT FOR NON-HODGKIN'S LYMPHOMA WITH LEADING MARKETED PRODUCT UP 200% AND RISING FAST,,HEDGE FUNDS ARE BUYING LARGEsize=4>color=RED> https://stockcharts.com/h-sc/ui?s=ixs.V&p=D&b=5&g=0&id=p95524307080 -PENDING NEWS OF 30 MILLION ROYALTY @ PRICE OF $ 1.01 GANA MAKE THIS STOCK FLY -DXL 625 is IXS's first drug offering that enhances or betters Rituxan a $2.06 Billion a year drug. -The animal testing results show that DXL 625 is more effective than Rituxan (remember a $2 Billion drug). -The CEO has indicated a 2nd drug is in the works and another $30 Million from Royalty will be soon be available to company @ price of $ 1.01 per share Show me another Biotech with this much going for it with such a low market cap. This thing is going to take off.------------- Recommandation *STRONG BUY* --------------size=4> THIS STOCK IS AT THE TOP OF THE PHARMACEUTICAL WORLD - PLACE YOUR BETS BUY LOW BEFORE HEADING TO DA MOOOOOOOOOON
Bullboard Posts